BETTINA LOPEZ CORDOVA: Open Payments
NPI 1992204853 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 14 payments from 8 companies in 2025. Trend: 2023 $2,114 · 2024 $1,511 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $324 |
| Neurocrine BioSciences, Inc. | 2 | $251 |
| Janssen Pharmaceuticals, Inc | 3 | $203 |
| Biogen, Inc. | 1 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $16 |
Products named: CAPLYTA, SPRAVATO, INGREZZA, ZURZUVAE, COBENFY, FANAPT, Auvelity, ARISTADA.
Industry payments across TX — which companies pay providers there.
